Related Experiment Video
Updated: Mar 9, 2026

Description of a Swine Infant Model of Volume-Controlled Hemorrhagic Shock
Published on: November 3, 2023
Ischemia modified albumin in perinatology
Aslı Yarcı Gursoy1, Gamze S Caglar1, Selda Demirtas2
1Ufuk University Faculty of Medicine, Obstetrics and Gynecology Department, Ankara, Turkey.
Abstract:
Ischemia modified albumin is a novel marker of ischemia generated due to hypooxygenation and increased hydroxyl free radicals in low pH. The molecule has been licenced for clinical use as an early marker for acute coronary syndrome in cardiology. Since presence of ischemia might have serious and sometimes devastating effects in perinatology, various researches have evaluated its value in different clinical conditions. This narrative review aims to summarize the literature concerning the value of IMA in perinatology and guide for further research.
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Pharmacokinetics in Pediatric Patients: Drug Distribution
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Acute Kidney Injury IV: Diagnostic Studies and Prevention

